Search alternatives:
teer decrease » greater decrease (Expand Search)
step decrease » sizes decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » greater decrease (Expand Search)
step decrease » sizes decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
11181
Chemoenzymatic Approach for the Proteomics Analysis of Mucin-Type Core‑1 O‑Glycosylation in Human Serum
Published 2018“…Human serum is a complex body fluid that contains various N-linked and O-linked glycoproteins. …”
-
11182
Chemoenzymatic Approach for the Proteomics Analysis of Mucin-Type Core‑1 O‑Glycosylation in Human Serum
Published 2018“…Human serum is a complex body fluid that contains various N-linked and O-linked glycoproteins. …”
-
11183
-
11184
-
11185
REG-O3 chimeric peptide combining growth hormone and somatostatin sequences improves joint function and prevents cartilage degradation in rat model of traumatic knee osteoarthritis
Published 2020“…The effect of REG-O3, solubilized in a liposomal solution and injected at either 5, 25 or 50 μg/50 μL, was compared to liposomal (LIP), dexamethasone and hyaluronic acid (HA) solutions. …”
-
11186
-
11187
-
11188
Efficacy and Acceptability of Glycemic Control of Glucagon-Like Peptide-1 Receptor Agonists among Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
Published 2016“…Dulaglutide, exenatide long-acting release (exe_lar), liraglutide and taspoglutide had significant lowering effect when compared with sitagliptin (HbA1c<7.0%) and insulin (HbA1c<6.5%). Finally, according to SUCRAs, placebo, thiazolidinediones and albiglutide had the best decrease effect on hypoglycemia; sulphanylureas, sitagliptin and insulin decrease the incidence of treatment discontinuation most; exe_lar and dulaglutide had the highest impact on glycemic level among 13 treatments.…”
-
11189
-
11190
Effect of partial Glo-I inhibition by EP on LPS-induced production of TNF-α, collagen-I and α-SMA in HSC.
Published 2017“…Presence of LPS and treatment with low-level concentrations of MGO (indicating partial inhibition of Glo-I activity without complete enzyme inhibition) showed significant decrease of LPS-induced release of TNF-α (absence vs. presence of 10mM MGO: 371.8±22.7 vs. 60.9±11.2 pg/ml; p<0.001), collagen-I (10.0±0.3 vs. 1.8±0.5 ng/ml; p<0.001) and α-SMA (68.6±3.6 vs. 43.8±2.2 ng/ml; p<0.001) <b>(A2, B2, C2)</b>. …”
-
11191
Effects of 20 μM 5-aza-dC Treatment on the 10q25 Neocentromere
Published 2013“…Six CpG islets (28, 31, 69, 70, 71, and 101) showed an increase in DNA methylation upon the formation of the 10q25 neocentromere. However, following 5-aza-dC treatment, the methylation level of these CpG islets decreased significantly. …”
-
11192
-
11193
LM11A-31's effect on cholinergic dystrophic neurites in cortex of mid-stage APP<sup>L/S</sup> mice.
Published 2014“…Scale bar in photomicrograph Aâ=â50 µm. Quantitative analysis showed that LM11A-31 decreases the total area occupied by the clusters (<b><i>C</i></b>) by decreasing their number (<b><i>D</i></b>) but not the mean area per cluster (<b><i>E</i></b>). …”
-
11194
-
11195
-
11196
Effects of COS on the expression of MCP-1 and iNOS mRNA in RGC-5 cells.
Published 2013“…<p>RGC-5 cells were stimulated with 0.5mM PQ and then treated with 50 μg/ml (low-dose) or 100 μg/ml (high-dose) COS for 12 hours. …”
-
11197
-
11198
Sensitivity of U251 stable clones to GCV.
Published 2021“…<p>U251, U251-pCMV-HSVtk, and U251-pGFAP-HSVtk cells were treated with 0, 1, 5, or10 μg/ml of GCV for 5 days. (A–D) Live-cell phase images of U251 parent cells displayed no cytotoxicity up to 10 μg/ml of GCV. …”
-
11199
-
11200
3D spheroids enhance NFAT3 and CXCR4 expression.
Published 2014“…(<b>C</b>) Corresponding to the increase in NFAT3 in 3D spheroids, real-time PCR showed a 30-50-fold increase in CXCR4 mRNA in 3D spheroids when compared to adherent HeyA8 cells. (*, P <0.05 vs Adh, 1-way ANOVA). …”